Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1336 publications
Global Breast Cancer Market Report: 2014 Edition US$ 800.00

... . The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, ... faced by the industry are elicited. On the contention front, the market is personified by the intense competition in terms of research and development of novel ...

Aug, 2014 65 pages
PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022 US$ 9,995.00

... GlobalData's report 'PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2022', provides comprehensive information on prostate cancer therapeutics, highlighting ... cancer patients, and how will this change over the forecast period? How will pipeline drugs attempt to meet these needs? ...

Nov, 2012 288 pages
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies US$ 3,900.00

... maintaining front line, product level access and education. In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord ... marketed and four pipeline products Examination of physicians’ current usage of Medical Affairs teams services Key findings regarding the most and ...

Aug, 2014 54 pages
Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation and Drive Growth in an Increasingly Competitive Market US$ 4,995.00

... provider, has released its latest research report, “Non-Small Cell Lung Cancer Market to 2020 - New Therapies to Enhance Treatment Segmentation ... most promising pipeline drugs. An epidemiological forecast of the major NSCLC markets, in which projected values include total and treated populations An in-depth ...

Jul, 2014 143 pages
Global Cancer Generics Market Outlook 2018 US$ 1,400.00

... growth. According to our latest research report “Global Cancer Generics Market Outlook 2018”, the global oncology market touched a mark of US$ 91 Billion in 2013 ... future incidences, regional analysis and patent expiration status of key cancer drugs. Analysis of key industry trends and drivers crucial to the ...

Aug, 2014 100 pages
Cancer Immunotherapy Market & Clinical Pipeline Insight US$ 3,000.00

... Hard Copy License. With more than 6 million deaths worldwide in 2013, cancer has become one of the most pressing health problems faced by ... which is one of the major reasons for cancer immunotherapy not being in widespread use. “Cancer Immunotherapy Market & Clinical Pipeline Insight” Report Highlights: ...

Jul, 2014 1990 pages
Uterine Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Uterine Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2014 US$ 1,250.00

... Cancer) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed ... . Devise corrective measures for pipeline projects by understanding Transitional Cell Cancer (Urothelial Cell Cancer) pipeline depth and focus of Indication therapeutics ...

Aug, 2014
Thyroid Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Thyroid Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Thymus Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Thymus Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Testicular Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Testicular Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Testicular Cancer. This ...

Aug, 2014
Squamous Non-Small Cell Lung Cancer-Pipeline Insights, 2014 US$ 1,250.00

... , development partner and chemical information Coverage of the Squamous Non-Small Cell Lung Cancer pipeline on the basis of target, MOA, route of administration, ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Skin Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Skin Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Recurrent Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014 US$ 1,250.00

... The report provides a snapshot of the global therapeutic landscape of Recurrent Head And Neck Cancer Squamous Cell Carcinoma The report provides pipeline ... and complete understanding over therapeutics development for Recurrent Head And Neck Cancer Squamous Cell Carcinoma Identify the relationship between the ...

Aug, 2014
Peritoneal Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Peritoneal Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peritoneal Cancer. This ...

Aug, 2014
Pediatric Cancer-Pipeline Insights, 2014 US$ 1,250.00

... SUMMARY DelveInsight’s,“ Pediatric Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Papillary Thyroid Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Papillary Thyroid Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Other Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Other Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2014 US$ 1,250.00

... information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, ... . Devise corrective measures for pipeline projects by understanding Non Muscle Invasive Bladder Cancer (NMIBC) pipeline depth and focus of Indication therapeutics ...

Aug, 2014
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2014 US$ 1,250.00

... information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, ... a snapshot of the global therapeutic landscape of Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) The report provides pipeline products ...

Aug, 2014
Nasopharyngeal Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Nasopharyngeal Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Nasopharyngeal Cancer. This report provides ...

Aug, 2014
Metastatic Renal Cell Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Renal Cell Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Prostate Cancer-Pipeline Insights, 2014 US$ 1,250.00

... SUMMARY DelveInsight’s,“ Metastatic Prostate Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Ovarian Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Ovarian Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Lung Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Lung Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Liver Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Metastatic Liver Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2014 US$ 1,250.00

... Cancer dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed ... , development partner and chemical information Coverage of the Metastatic Hormone Refractory Prostate Cancer pipeline on the basis of target, MOA, route of administration ...

Aug, 2014
Medullary Thyroid Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Medullary Thyroid Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Human papillomavirus (HPV) Associated Cancer-Pipeline Insights, 2014 US$ 1,250.00

... the understanding for all the pipeline drugs that fall under Human papillomavirus (HPV) Associated Cancer. This report provides information ... , development partner and chemical information Coverage of the Human papillomavirus (HPV) Associated Cancer pipeline on the basis of target, MOA, route of administration ...

Aug, 2014
Hormone Refractory Breast Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Hormone Refractory Breast Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insights, 2014 US$ 1,250.00

... The report provides a snapshot of the global therapeutic landscape of Head And Neck Cancer Squamous Cell Carcinoma The report provides pipeline products ... . Devise corrective measures for pipeline projects by understanding Head And Neck Cancer Squamous Cell Carcinoma pipeline depth and focus of Indication ...

Aug, 2014
Gynecological Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Gynecological Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Gynecological Cancer. ...

Aug, 2014
Gastrointestinal Tract Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Gastrointestinal Tract Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Gastrointestinal ...

Aug, 2014
Gallbladder Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Gallbladder Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Gallbladder Cancer. ...

Aug, 2014
Fallopian Tube Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Fallopian Tube Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Esophageal Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Esophageal Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Esophageal Cancer. This ...

Aug, 2014
Epithelial Ovarian Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Epithelial Ovarian Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Endometrial Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Endometrial Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Endometrial Cancer. ...

Aug, 2014
Cancer Cachexia-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Cancer Cachexia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Cancer Anorexia-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Cancer Anorexia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Brain Cancer-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Brain Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ... projects and understanding the factors that drove them from pipeline Gaining a Full Picture of the Competitive Landscape for Evidence based ...

Aug, 2014
Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2014 US$ 1,250.00

... this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Bile Duct ... , development partner and chemical information Coverage of the Bile Duct Cancer (Cholangiocarcinoma) pipeline on the basis of target, MOA, route of administration, technology ...

Aug, 2014
Oncology Market Access Europe – Payer and Industry Perspectives US$ 995.00

... experts from the UK, Germany, Italy, France and Spain, FirstWord’s Oncology Market Access Europe – Payer and Industry Perspectives lays out the current – and growing – challenges facing companies in getting drugs to the European market. Filled with compelling insight into the most pressing issues ranging ...

Jul, 2014 75 pages
2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals,... US$ 9,800.00

... be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the US Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... growing demand for malignancy assays and the rapid market expansion. US Market Overview Five-year test volume and sales projections ...

Jul, 2014 620 pages
2014 Market Segmentation Analysis of the UK Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

Jul, 2014 565 pages
2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Spanish Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Spanish Market Overview Five-year test volume and sales ...

Jul, 2014 565 pages
2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 8,800.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Japanese Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Japanese Market Overview Five-year test volume and sales ...

Jul, 2014 590 pages
2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. Italian Market Overview Five-year test volume and sales ...

Jul, 2014 570 pages
2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals,... US$ 6,700.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. German Market Overview Five-year test volume and sales ...

Jul, 2014 585 pages
2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and... US$ 6,700.00

... and can be custom-tailored to your specific information needs and budget. 2014 Market Segmentation Analysis of the French Cancer Diagnostics Industry: Oncogenes, Biochemical ... the growing demand for malignancy assays and the rapid market expansion. French Market Overview Five-year test volume and sales ...

Jul, 2014 585 pages
1 2 3 4 5 >
Skip to top